Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Pluri Signs Exclusive Collaboration With Hemafund To Establish Initiative For Stockpiling, Distribution and Potential Clinical Advancement Of Pluri's PLX-R18 Cell Therapy For Hematopoietic Acute Radiation Syndrome; Says Collaboration 'may potentially generate over $100 million in value for both parties'

Author: Benzinga Newsdesk | March 05, 2025 07:08am

Posted In: PLUR